Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 35

1.

Assessing the Learning Curve of Holmium Laser Enucleation of Prostate (HoLEP). A Systematic Review.

Kampantais S, Dimopoulos P, Tasleem A, Acher P, Gordon K, Young A.

Urology. 2018 Oct;120:9-22. doi: 10.1016/j.urology.2018.06.012. Epub 2018 Jul 4. Review.

PMID:
30403609
2.

Day-case holmium laser enucleation of the prostate: feasibility, safety and predictive factors.

Lee SM, Gordon K, McMillan R, Crystal F, Acher P.

Ann R Coll Surg Engl. 2018 Jul;100(6):475-479. doi: 10.1308/rcsann.2018.0039. Epub 2018 Mar 15.

PMID:
29543065
3.

Multiparametric ultrasound findings of tuberculous orchitis following bacillus Calmette-Guérin therapy.

Ahmed R, Wolfe K, Acher P, Liyanage S.

Radiol Case Rep. 2017 Sep 12;12(4):746-751. doi: 10.1016/j.radcr.2017.08.005. eCollection 2017 Dec.

4.

The CADMUS trial - Multi-parametric ultrasound targeted biopsies compared to multi-parametric MRI targeted biopsies in the diagnosis of clinically significant prostate cancer.

Grey A, Scott R, Charman S, van der Meulen J, Frinking P, Acher P, Liyanage S, Madaan S, Constantinescu G, Shah B, Graves CB, Freeman A, Jameson C, Ramachandran N, Emberton M, Arya M, Ahmed HU.

Contemp Clin Trials. 2018 Mar;66:86-92. doi: 10.1016/j.cct.2017.10.011. Epub 2017 Nov 3.

5.

Toward an MRI-based nomogram for the prediction of transperineal prostate biopsy outcome: A physician and patient decision tool.

Lee SM, Liyanage SH, Wulaningsih W, Wolfe K, Carr T, Younis C, Van Hemelrijck M, Popert R, Acher P.

Urol Oncol. 2017 Nov;35(11):664.e11-664.e18. doi: 10.1016/j.urolonc.2017.07.018. Epub 2017 Aug 8.

PMID:
28801025
6.

Diagnostic value of MRI-based PSA density in predicting transperineal sector-guided prostate biopsy outcomes.

MacAskill F, Lee SM, Eldred-Evans D, Wulaningsih W, Popert R, Wolfe K, Van Hemelrijck M, Rottenberg G, Liyanage SH, Acher P.

Int Urol Nephrol. 2017 Aug;49(8):1335-1342. doi: 10.1007/s11255-017-1609-8. Epub 2017 May 5.

PMID:
28477301
7.

Management of refractory haematuria following radiation therapy and recurrent adenocarcinoma of the prostate with fluoroscopic-guided selective pelvic embolization.

Konczalik W, Acher P, Tam M, Lodge R.

BJR Case Rep. 2016 Nov 2;2(4):20150031. doi: 10.1259/bjrcr.20150031. eCollection 2016.

8.

The Use of Transperineal Sector Biopsy as A First-Line Biopsy Strategy: A Multi-Institutional Analysis of Clinical Outcomes and Complications.

Eldred-Evans D, Kasivisvanathan V, Khan F, Hemelrijck MV, Polson A, Acher P, Popert R.

Urol J. 2016 Oct 10;13(5):2849-2855.

9.

Radiologic presentation of chronic granulomatous prostatitis mimicking locally advanced prostate adenocarcinoma.

Lee SM, Joshi J, Wolfe K, Acher P, Liyanage SH.

Radiol Case Rep. 2016 Mar 16;11(2):78-82. doi: 10.1016/j.radcr.2016.02.009. eCollection 2016 Jun.

10.

Confirmatory biopsy for the assessment of prostate cancer in men considering active surveillance: reference centre experience.

Bosco C, Cozzi G, Kinsella J, Bianchi R, Acher P, Challacombe B, Popert R, Brown C, George G, Van Hemelrijck M, Cahill D.

Ecancermedicalscience. 2016 Apr 14;10:633. doi: 10.3332/ecancer.2016.633. eCollection 2016.

11.

Transperineal prostate biopsies for diagnosis of prostate cancer are well tolerated: a prospective study using patient-reported outcome measures.

Wadhwa K, Carmona-Echeveria L, Kuru T, Gaziev G, Serrao E, Parashar D, Frey J, Dimov I, Seidenader J, Acher P, Muir G, Doble A, Gnanapragasam V, Hadaschik B, Kastner C.

Asian J Androl. 2017 Jan-Feb;19(1):62-66. doi: 10.4103/1008-682X.173453.

12.

Diagnostic accuracy of magnetic resonance imaging (MRI) prostate imaging reporting and data system (PI-RADS) scoring in a transperineal prostate biopsy setting.

Grey AD, Chana MS, Popert R, Wolfe K, Liyanage SH, Acher PL.

BJU Int. 2015 May;115(5):728-35. doi: 10.1111/bju.12862. Epub 2014 Oct 22.

13.

Indications, results and safety profile of transperineal sector biopsies (TPSB) of the prostate: a single centre experience of 634 cases.

Vyas L, Acher P, Kinsella J, Challacombe B, Chang RT, Sturch P, Cahill D, Chandra A, Popert R.

BJU Int. 2014 Jul;114(1):32-7. doi: 10.1111/bju.12282. Epub 2014 Apr 3.

14.

Prostate biopsy: will transperineal replace transrectal?

Acher P, Dooldeniya M.

BJU Int. 2013 Sep;112(5):533-4. doi: 10.1111/bju.12299. No abstract available.

15.

Introducing holmium laser enucleation of the prostate alongside transurethral resection of the prostate improves outcomes of each procedure.

Wilson N, Mikhail M, Acher P, Lodge R, Young A.

Ann R Coll Surg Engl. 2013 Jul;95(5):365-8. doi: 10.1308/003588413X13629960046273.

16.

Demonstration of erectile management techniques to men scheduled for radical prostatectomy reduces long-term regret: a comparative cohort study.

Kinsella J, Acher P, Ashfield A, Chatterton K, Dasgupta P, Cahill D, Popert R, O'Brien T.

BJU Int. 2012 Jan;109(2):254-8. doi: 10.1111/j.1464-410X.2011.10237.x. Epub 2011 Aug 25.

17.

Positive visualization of implanted devices with susceptibility gradient mapping using the original resolution.

Varma G, Clough RE, Acher P, Sénégas J, Dahnke H, Keevil SF, Schaeffter T.

Magn Reson Med. 2011 May;65(5):1483-90. doi: 10.1002/mrm.22710. Epub 2010 Dec 16.

18.

Redefining the limits of flexible ureterorenoscopy.

Hussain M, Acher P, Penev B, Cynk M.

J Endourol. 2011 Jan;25(1):45-9. doi: 10.1089/end.2010.0236. Epub 2010 Nov 4.

PMID:
21050026
19.

Vesico-acetabular cutaneous fistula: a delayed complication of hip surgery.

Jones AL, Acher P, Cynk M.

Urology. 2011 Aug;78(2):323-4. doi: 10.1016/j.urology.2010.06.007. Epub 2010 Aug 12.

PMID:
20708222
20.

An analysis of intraoperative versus post-operative dosimetry with CT, CT-MRI fusion and XMR for the evaluation of permanent prostate brachytherapy implants.

Acher P, Puttagunta S, Rhode K, Morris S, Kinsella J, Gaya A, Dasgupta P, Deehan C, Beaney R, Popert R, Keevil S.

Radiother Oncol. 2010 Aug;96(2):166-71. doi: 10.1016/j.radonc.2010.06.003. Epub 2010 Jul 6.

PMID:
20615565

Supplemental Content

Support Center